CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
作者信息
Kranz Lena M, Beck Jan D, Grunwitz Christian, Hotz Christian, Vormehr Mathias, Diken Mustafa
机构信息
a BioNTech RNA Pharmaceuticals GmbH , Mainz , Germany.
b TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH , Mainz , Germany.
出版信息
Hum Vaccin Immunother. 2017 Oct 3;13(10):2272-2279. doi: 10.1080/21645515.2017.1358327.
Abstract
摘要
相似文献
1
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.2017年国际肿瘤免疫治疗学会年会：周年研讨会——第15届国际肿瘤免疫治疗学会年会报告
Hum Vaccin Immunother. 2017 Oct 3;13(10):2272-2279. doi: 10.1080/21645515.2017.1358327.
2
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.2014年癌症免疫治疗进展：癌症免疫治疗协会第12届年会报告——2014年5月6 - 8日于德国美因茨召开
Hum Vaccin Immunother. 2014;10(10):3090-100. doi: 10.4161/hv.29767.
3
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?胰腺导管腺癌的免疫治疗：我们现在在哪里？
World J Gastroenterol. 2018 May 28;24(20):2137-2151. doi: 10.3748/wjg.v24.i20.2137.
4
Clinical development of immunotherapy for prostate cancer.前列腺癌免疫疗法的临床开发
Int J Urol. 2017 Sep;24(9):675-680. doi: 10.1111/iju.13397. Epub 2017 Jun 21.
5
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.食管癌的免疫治疗：现状、多项试验和创新策略。
Oncol Res Treat. 2018;41(5):266-271. doi: 10.1159/000488120. Epub 2018 Apr 20.
6
Let's fight cancer: let-7 is a tool to enhance antitumor immune responses.让我们抗击癌症：let-7是增强抗肿瘤免疫反应的一种工具。
Future Oncol. 2018 May;14(12):1141-1145. doi: 10.2217/fon-2018-0037. Epub 2018 Apr 23.
7
The current landscape of early drug development for patients with sarcoma in the immunotherapy era.免疫治疗时代肉瘤患者早期药物开发的现状。
Future Oncol. 2018 May;14(12):1197-1211. doi: 10.2217/fon-2017-0565. Epub 2018 Apr 27.
8
Combinatorial Cancer Immunotherapies.组合式癌症免疫疗法。
Adv Immunol. 2016;130:251-77. doi: 10.1016/bs.ai.2015.12.005. Epub 2016 Jan 12.
9
Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.癌症免疫疗法取得突破性进展：2014年5月6日至8日于德国美因茨召开的癌症免疫疗法协会（CIMT）第12届年会。
Cancer Immunol Immunother. 2015 Jul;64(7):923-30. doi: 10.1007/s00262-014-1643-7. Epub 2014 Dec 30.
10
Women's cancer: Advancing molecular and immunotherapy.女性癌症：推进分子疗法与免疫疗法
Curr Probl Cancer. 2017 Jan-Feb;41(1):7. doi: 10.1016/j.currproblcancer.2017.02.004.
本文引用的文献
1
Immune checkpoints on innate lymphoid cells.天然淋巴细胞上的免疫检查点。
J Exp Med. 2017 Jun 5;214(6):1561-1563. doi: 10.1084/jem.20170763. Epub 2017 May 17.
2
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect.利用多价效应通过合成树突状细胞控制T细胞活化
ACS Omega. 2017 Mar 31;2(3):937-945. doi: 10.1021/acsomega.6b00436. Epub 2017 Mar 16.
3
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.对连续进行CTLA-4和PD-1阻断治疗的肿瘤活检组织进行综合分子分析，揭示了反应和耐药的标志物。
Sci Transl Med. 2017 Mar 1;9(379). doi: 10.1126/scitranslmed.aah3560.
4
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.程序性死亡配体1的表达及黑色素瘤对抗程序性死亡1抗体帕博利珠单抗的反应
J Clin Oncol. 2016 Dec;34(34):4102-4109. doi: 10.1200/JCO.2016.67.2477. Epub 2016 Oct 31.
5
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
6
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.基于表观遗传学特征对不明原发灶癌进行分类：一项多中心、回顾性分析。
Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. Epub 2016 Aug 27.
7
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer.结直肠肿瘤内的表观遗传同质性预示着局部区域性癌症患者的无复发生存期和总生存期更短。
Gastroenterology. 2016 Nov;151(5):961-972. doi: 10.1053/j.gastro.2016.08.001. Epub 2016 Aug 10.
8
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.与黑色素瘤中PD-1阻断获得性耐药相关的突变
N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13.
9
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.系统性 RNA 递送至树突状细胞利用抗病毒防御机制进行癌症免疫治疗。
Nature. 2016 Jun 16;534(7607):396-401. doi: 10.1038/nature18300. Epub 2016 Jun 1.
10
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.利用供体来源的 T 细胞受体库靶向癌症新生抗原。
Science. 2016 Jun 10;352(6291):1337-41. doi: 10.1126/science.aaf2288. Epub 2016 May 19.
Zotero 插件